Suven Life Sciences Management
Management criteria checks 2/4
Suven Life Sciences' CEO is Venkat Jasti, appointed in Oct 2004, has a tenure of 20.08 years. directly owns 0.001% of the company’s shares, worth ₹266.07K. The average tenure of the management team and the board of directors is 14.2 years and 10.5 years respectively.
Key information
Venkat Jasti
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 20.1yrs |
CEO ownership | 0.001% |
Management average tenure | 14.2yrs |
Board average tenure | 10.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -₹1b |
Jun 30 2024 | n/a | n/a | -₹1b |
Mar 31 2024 | n/a | n/a | -₹1b |
Dec 31 2023 | n/a | n/a | -₹1b |
Sep 30 2023 | n/a | n/a | -₹1b |
Jun 30 2023 | n/a | n/a | -₹1b |
Mar 31 2023 | n/a | n/a | -₹1b |
Dec 31 2022 | n/a | n/a | -₹1b |
Sep 30 2022 | n/a | n/a | -₹940m |
Jun 30 2022 | n/a | n/a | -₹991m |
Mar 31 2022 | n/a | n/a | -₹1b |
Dec 31 2021 | n/a | n/a | -₹1b |
Sep 30 2021 | n/a | n/a | -₹1b |
Jun 30 2021 | n/a | n/a | -₹1b |
Mar 31 2021 | n/a | n/a | -₹722m |
Dec 31 2020 | n/a | n/a | -₹761m |
Sep 30 2020 | n/a | n/a | -₹745m |
Jun 30 2020 | n/a | n/a | -₹787m |
Mar 31 2020 | n/a | n/a | -₹942m |
Dec 31 2019 | n/a | n/a | ₹28m |
Sep 30 2019 | n/a | n/a | ₹1b |
Jun 30 2019 | n/a | n/a | ₹871m |
Mar 31 2019 | ₹58m | ₹29m | -₹239m |
Mar 31 2018 | ₹47m | ₹25m | ₹1b |
Compensation vs Market: Insufficient data to establish whether Venkat's total compensation is reasonable compared to companies of similar size in the Indian market.
Compensation vs Earnings: Venkat's compensation has increased whilst the company is unprofitable.
CEO
Venkat Jasti (75 yo)
20.1yrs
Tenure
Mr. Venkateswarlu Jasti, also known as Venkat, M.Pharm. M.S., has been the Managing Director and Executive Chairman of the Board of Suven Life Sciences Limited since November 01, 2024. He is Member of Advi...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & Executive Chairman | 20.1yrs | no data | 0.0010% ₹ 266.1k | |
Whole-Time Director | 35.7yrs | ₹9.99m | 0.70% ₹ 184.6m | |
Chief Financial Officer | 4.8yrs | no data | no data | |
Company Secretary & Compliance Officer | less than a year | no data | no data | |
President of US Operations | 14.2yrs | no data | 0.00046% ₹ 121.2k |
14.2yrs
Average Tenure
70yo
Average Age
Experienced Management: 530239's management team is seasoned and experienced (14.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & Executive Chairman | 35.7yrs | no data | 0.0010% ₹ 266.1k | |
Whole-Time Director | 35.7yrs | ₹9.99m | 0.70% ₹ 184.6m | |
Non-Independent & Non-Executive Director | 14.6yrs | ₹200.00k | no data | |
Independent Non-Executive Director | 6.5yrs | ₹250.00k | no data | |
Independent Non-Executive Director | 6yrs | ₹110.00k | no data | |
Independent Director | less than a year | no data | no data |
10.5yrs
Average Tenure
70yo
Average Age
Experienced Board: 530239's board of directors are seasoned and experienced ( 10.5 years average tenure).